Chris Chin
Analyst
Baird
Equibles does not estimate personal net worth.
About Chris Chin
Chris Chin is recorded as Analyst at Baird. Chris Chin has spoken on 1 earnings call across 1 company, most recently for Definium Therapeutics, Inc. on November 9, 2026. The companies whose calls Chris Chin spoke on are classified in the Healthcare sector.
Chris Chin on recent calls
“Just one turning back to 120, as you've had more time to dig into the data across the three trials there, can you share any updates on how patient profile may be impacting response and remission rates, and are you able to point to any key drivers that may be separating those responders from non-responders and…”
Affiliation history
-
Baird
Analyst
Transcript header (unverified)
Current